CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
November 2023—HemoSonics announced that its Quantra hemostasis system received an Innovative Technology contract award from Vizient. The Quantra system consists of the Quantra hemostasis analyzer with QPlus and QStat cartridges and provides comprehensive whole-blood coagulation analysis at the point of care in less than 15 minutes.
“Our member councils reviewed and recommended the Quantra hemostasis system for an Innovative Technology contract based on its potential to make an incremental difference in health care,” Kelly Flaharty, senior director of contract services for Vizient, said in a press release.
Vizient’s membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks, and nonacute health care providers and represents more than $130 billion in annual purchasing volume.
HemoSonics, 800-280-5589